China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
CN |
|
Suprajit Engineering Ltd
NSE:SUPRAJIT
|
IN |
|
Legal & General Group PLC
LSE:LGEN
|
UK |
|
H
|
HK Acquisition Corp
HKEX:7841
|
HK |
|
T
|
TTK Healthcare Ltd
NSE:TTKHLTCARE
|
IN |
|
S
|
Shalimar Wires Industries Ltd
BSE:532455
|
IN |
|
Impro Precision Industries Ltd
HKEX:1286
|
HK |
Wall Street
Price Targets
Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
China Resources Boya Bio pharmaceutical Group Co Ltd
is 31.78 CNY
with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
31.78
CNY
According to Wall Street analysts, the average 1-year price target for
China Resources Boya Bio pharmaceutical Group Co Ltd
is 31.78 CNY
with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is
18%.
The projected
CAGR
for the next 2 years is
10%.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
55%
For the last 14 years the
compound annual growth rate for
China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is
11%.
The projected
CAGR
for the next 3 years is
55%.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
148%
For the last 14 years the
compound annual growth rate for
China Resources Boya Bio pharmaceutical Group Co Ltd's net income is
4%.
The projected
CAGR
for the next 2 years is
148%.